Oxycontin (Oxycodone HCl) Patent Expiration, LOE Window & CMS Spending
Oxycontin (Oxycodone HCl) by Knoa: FDA Orange Book LOE 2030-03-29, 14 AB generics, $397.4M 2024 CMS Part D & Medicaid spend, and 42 CA HCAI SB 17 wholesale price filings.
| Regulatory & Reimbursement Dimension | Verified Value |
|---|---|
| Consolidated Sponsor | Knoa |
| FDA Application & Pathway | N022272 (NDA) |
| Exclusivity / Cliff Horizon | Near-Term Cliff (2028-2030) |
| Core Active-Ingredient LOE Date | Not listed / N/A |
| Last Listed Patent or Exclusivity Date | 2030-03-29 |
| Orange Book Patents (*PED Extensions) | 15 patents (0 *PED) |
| Active AB-Rated Generic Competitors | 14 |
| 2024 CMS Total Public Spend | $397.4M |
| 2024 Medicare Part D Spend | $337.8M |
| 2024 Medicaid Spend | $59.6M |
| Reported Wholesale Price Change (CA SB 17) | 42 WAC filings (max 25.7% 2-yr change) |